ADRENAL-SPECIFIC RADIOLIGAND, 131I-6β-iodomethyl-19norcholest-5(10)-en-3β-ol (131I-adosterol)1 was developed in the 1970s. Increased uptake of the agent in tumor regardless of visualization of the contralateral gland suggests that the adrenal mass is usually a benign cortical adenoma.2 This agent has the potency to diagnose lesions of the adrenal cortex and has been widely used to diagnose lesi...

Veterinarians are often presented with complex adrenal neoplasia cases that have significant intraoperative challenges, which require the skills of an experienced surgeon. Perioperative evaluation and treatment of these patients can be equally challenging, and successful outcomes require a thorough understanding of the tumor types that affect the adrenal glands, as well as an understanding of a...

Nonfunctional adrenocortical carcinoma is an extremely rare malignant tumor in children. Unlike the functional tumor which is detected early due to its hormonal presentation, nonfunctional tumor is detected at a later stage. Here we report a case of a 10 year old girl who presented with abdominal mass and symptoms of short duration. No hypertension and cushingoid features were seen. Serum alpha...

A 60-year-old woman presented with synchronous adrenal metastasis and an inferior vena cava tumor thrombus in the adrenal vein that developed from an ovarian carcinoma. The patient underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and right adrenalectomy with caval tumor thrombectomy for treatment. Microscopic examination revealed a clear cell ovarian carcinoma and a meta...

Adrenal cell carcinoma is a rare tumor and more than 70% of patients present with advanced stages. Adrenal cell carcinoma is an aggressive tumor with a poor prognosis. Surgical intervention is the gold standard treatment and mitotane is the only drug approved for the treatment of adrenal cell carcinoma. Until recently in 2012, the etoposide, doxorubicin, cisplatin plus mitotane are approved as ...

A 50 years old woman with history of pancreatic neuroendocrine tumor diagnosed 2 years ago, which has not been surgically removed,was referred to our department for a 99mTc-Octreotate in order to evaluate the somatostatin receptor status. She was treated with regular sandostatin injections and chemotherapy. Her CT scan which was previously performed confirmed lung, adrenal and hepati...

Abstract Introduction Pheochromocytomas are rare neuroendocrine catecholamine-producing tumors that arise from either the adrenal medulla (PHEO) or extra-adrenal paraganglionic tissues (paraganglioma/PGLs). PHEO is responsible for about 0.01–0.1% of cases hypertension. Assessment plasma/urinary levels metanephrines (catecholamines metabolites) now considered gold standard diagnosis PHEOs. In th...

UNLABELLED Composite pheochromocytoma/paraganglioma is a rare tumor with elements of pheochromocytoma/paraganglioma and neurogenic tumor. Most were located in the adrenal glands, and extra-adrenal composite pheochromocytoma is extremely rare. Only 4 cases in the retroperitoneum have been described in the online database PUBMED. Here, we report a case of retroperitoneal extra-adrenal composite p...